William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
BioDelivery Sciences to Present at the William Blair 2018 Growth Stock Conference
-
BioDelivery Sciences (BDSI) Reports Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
-
BioDelivery Sciences (BDSI) Prices $50M of Equity Financing
-
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
-
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
-
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
-
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
-
BioDelivery Sciences to Present at the Jefferies 2017 Healthcare Conference and the William Blair 2017 Growth Stock Conference
-
BioDelivery Sciences to Present at the William Blair Annual Growth Stock Conference
-
BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference
-
BioDelivery Sciences (BDSI) BUNAVAIL NDA Approved by U.S. FDA
-
BioDelivery Sciences (BDSI) Receives FDA Approval for BUNAVAIL
-
William Blair's 2014 Top Small-Cap Picks
-
BioDelivery Sciences (BDSI) Enters $40M Committed Financing
-
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
-
William Blair Starts BioDelivery Sciences International (BDSI) at Outperform, Sets $4 Price Target

